BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 12907335)

  • 1. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
    Bernstein CN; Blanchard JF; Metge C; Yogendran M
    Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
    Bernstein CN; Blanchard JF; Metge C; Yogendran M
    Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
    Metge CJ; Blanchard JF; Peterson S; Bernstein CN
    Am J Gastroenterol; 2001 Dec; 96(12):3348-55. PubMed ID: 11774948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA; Hamdy NA
    Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Wajda A; Blanchard JF
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.
    Bernstein CN; Nugent Z; Longobardi T; Blanchard JF
    Am J Gastroenterol; 2009 Nov; 104(11):2774-8. PubMed ID: 19623167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between inflammatory bowel disease and socioeconomic variables.
    Bernstein CN; Kraut A; Blanchard JF; Rawsthorne P; Yu N; Walld R
    Am J Gastroenterol; 2001 Jul; 96(7):2117-25. PubMed ID: 11467642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study.
    Singh H; Demers AA; Nugent Z; Mahmud SM; Kliewer EV; Bernstein CN
    Gastroenterology; 2009 Feb; 136(2):451-8. PubMed ID: 18996382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
    Bernstein CN; Blanchard JF; Houston DS; Wajda A
    Thromb Haemost; 2001 Mar; 85(3):430-4. PubMed ID: 11307809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Wajda A; Blanchard JF
    Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
    Gupta G; Gelfand JM; Lewis JD
    Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis.
    Shaw SY; Blanchard JF; Bernstein CN
    Am J Gastroenterol; 2011 Dec; 106(12):2133-42. PubMed ID: 21912437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
    Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark.
    Li J; Nørgard B; Precht DH; Olsen J
    Am J Gastroenterol; 2004 Jun; 99(6):1129-33. PubMed ID: 15180736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.